Schedule 13G ownership disclosure
NEUROCRINE BIOSCIENCES INC COM
COMMON STOCK · CUSIP: 64125C109
Event date: 2024-12-31
- Filing-level shares
- 4,891,137.00
- Percent of class
- 4.8%
- STATE STREET CORPORATION
Shares: 4,891,137.00 · Class: 4.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000093751-25-000054
- Form type
- SCHEDULE 13G
- Filer
- NEUROCRINE BIOSCIENCES INC
- CIK
- CIK 914475
- Filed
- Feb 05, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership